BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 7777059)

  • 1. Glucosylation of Rho proteins by Clostridium difficile toxin B.
    Just I; Selzer J; Wilm M; von Eichel-Streiber C; Mann M; Aktories K
    Nature; 1995 Jun; 375(6531):500-3. PubMed ID: 7777059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling.
    Sehr P; Joseph G; Genth H; Just I; Pick E; Aktories K
    Biochemistry; 1998 Apr; 37(15):5296-304. PubMed ID: 9548761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EhRho1, a RhoA-like GTPase of Entamoeba histolytica, is modified by clostridial glucosylating cytotoxins.
    Majumder S; Schmidt G; Lohia A; Aktories K
    Appl Environ Microbiol; 2006 Dec; 72(12):7842-8. PubMed ID: 17056697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile.
    Just I; Selzer J; von Eichel-Streiber C; Aktories K
    J Clin Invest; 1995 Mar; 95(3):1026-31. PubMed ID: 7883950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1.
    Schmidt G; Sehr P; Wilm M; Selzer J; Mann M; Aktories K
    Nature; 1997 Jun; 387(6634):725-9. PubMed ID: 9192900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine.
    Flatau G; Lemichez E; Gauthier M; Chardin P; Paris S; Fiorentini C; Boquet P
    Nature; 1997 Jun; 387(6634):729-33. PubMed ID: 9192901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
    Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
    Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation.
    Popoff MR; Chaves-Olarte E; Lemichez E; von Eichel-Streiber C; Thelestam M; Chardin P; Cussac D; Antonny B; Chavrier P; Flatau G; Giry M; de Gunzburg J; Boquet P
    J Biol Chem; 1996 Apr; 271(17):10217-24. PubMed ID: 8626586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.
    Dreikhausen U; Varga G; Hofmann F; Barth H; Aktories K; Resch K; Szamel M
    Eur J Immunol; 2001 May; 31(5):1610-9. PubMed ID: 11465119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins.
    Just I; Hofmann F; Genth H; Gerhard R
    Int J Med Microbiol; 2001 Sep; 291(4):243-50. PubMed ID: 11680784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.
    Just I; Wilm M; Selzer J; Rex G; von Eichel-Streiber C; Mann M; Aktories K
    J Biol Chem; 1995 Jun; 270(23):13932-6. PubMed ID: 7775453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of cellular proteins in response to treatment with Clostridium difficile toxin B and Clostridium sordellii toxin L.
    Ciesielski-Treska J; Ulrich G; Baldacini O; Monteil H; Aunis D
    Eur J Cell Biol; 1991 Oct; 56(1):68-78. PubMed ID: 1724754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin.
    Hofmann F; Busch C; Prepens U; Just I; Aktories K
    J Biol Chem; 1997 Apr; 272(17):11074-8. PubMed ID: 9111001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion.
    Spyres LM; Qa'Dan M; Meader A; Tomasek JJ; Howard EW; Ballard JD
    Infect Immun; 2001 Jan; 69(1):599-601. PubMed ID: 11119561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors--reinforcing the critical role of RhoA in cytokinesis.
    Huelsenbeck SC; May M; Schmidt G; Genth H
    Cell Motil Cytoskeleton; 2009 Nov; 66(11):967-75. PubMed ID: 19504561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
    Jank T; Aktories K
    Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B.
    Genth H; Huelsenbeck J; Hartmann B; Hofmann F; Just I; Gerhard R
    FEBS Lett; 2006 Jun; 580(14):3565-9. PubMed ID: 16730714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1.
    Halabi-Cabezon I; Huelsenbeck J; May M; Ladwein M; Rottner K; Just I; Genth H
    FEBS Lett; 2008 Nov; 582(27):3751-6. PubMed ID: 18848548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function.
    Jank T; Giesemann T; Aktories K
    Glycobiology; 2007 Apr; 17(4):15R-22R. PubMed ID: 17237138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.